Integrating Single-Cell and Spatial Transcriptomics to Uncover and Elucidate GP73-Mediated Pro-Angiogenic Regulatory Networks in Hepatocellular Carcinoma
Jiazhou Ye,
Xing Gao,
Xi Huang,
Shilin Huang,
Dandan Zeng,
Wenfeng Luo,
Can Zeng,
Cheng Lu,
Lu Lu,
Hongyang Huang,
Kaixiang Mo,
Julu Huang,
Shizhou Li,
Minchao Tang,
Tianzhun Wu,
Rongyun Mai,
Min Luo,
Mingzhi Xie,
Shan Wang,
Yongqiang Li,
Yan Lin,
Rong Liang
Affiliations
Jiazhou Ye
Department of Hepatobiliary Surgery,
Guangxi Medical University Cancer Hospital, Nanning 530021, China.
Xing Gao
Guangxi Liver Cancer Diagnosis and Treatment Project Technology Research Center, Nanning 530021, China.
Xi Huang
Guangxi Liver Cancer Diagnosis and Treatment Project Technology Research Center, Nanning 530021, China.
Shilin Huang
Guangxi Liver Cancer Diagnosis and Treatment Project Technology Research Center, Nanning 530021, China.
Dandan Zeng
Guangxi Liver Cancer Diagnosis and Treatment Project Technology Research Center, Nanning 530021, China.
Wenfeng Luo
Guangxi Liver Cancer Diagnosis and Treatment Project Technology Research Center, Nanning 530021, China.
Can Zeng
Department of Hepatobiliary Surgery,
Guangxi Medical University Cancer Hospital, Nanning 530021, China.
Cheng Lu
Department of Hepatobiliary Surgery,
Guangxi Medical University Cancer Hospital, Nanning 530021, China.
Lu Lu
Guangxi Liver Cancer Diagnosis and Treatment Project Technology Research Center, Nanning 530021, China.
Hongyang Huang
Department of Hepatobiliary Surgery,
Guangxi Medical University Cancer Hospital, Nanning 530021, China.
Kaixiang Mo
Department of Hepatobiliary Surgery,
Guangxi Medical University Cancer Hospital, Nanning 530021, China.
Julu Huang
Department of Hepatobiliary Surgery,
Guangxi Medical University Cancer Hospital, Nanning 530021, China.
Shizhou Li
Department of Hepatobiliary Surgery,
Guangxi Medical University Cancer Hospital, Nanning 530021, China.
Minchao Tang
Department of Hepatobiliary Surgery,
Guangxi Medical University Cancer Hospital, Nanning 530021, China.
Tianzhun Wu
Guangxi Liver Cancer Diagnosis and Treatment Project Technology Research Center, Nanning 530021, China.
Rongyun Mai
Department of Hepatobiliary Surgery,
Guangxi Medical University Cancer Hospital, Nanning 530021, China.
Min Luo
Guangxi Liver Cancer Diagnosis and Treatment Project Technology Research Center, Nanning 530021, China.
Mingzhi Xie
Guangxi Liver Cancer Diagnosis and Treatment Project Technology Research Center, Nanning 530021, China.
Shan Wang
Guangxi Liver Cancer Diagnosis and Treatment Project Technology Research Center, Nanning 530021, China.
Yongqiang Li
Guangxi Liver Cancer Diagnosis and Treatment Project Technology Research Center, Nanning 530021, China.
Yan Lin
Guangxi Liver Cancer Diagnosis and Treatment Project Technology Research Center, Nanning 530021, China.
Rong Liang
Guangxi Liver Cancer Diagnosis and Treatment Project Technology Research Center, Nanning 530021, China.
Hepatocellular carcinoma (HCC) was characterized as being hypervascular. In the present study, we generated a single-cell spatial transcriptomic landscape of the vasculogenic etiology of HCC and illustrated overexpressed Golgi phosphoprotein 73 (GP73) HCC cells exerting cellular communication with vascular endothelial cells with high pro-angiogenesis potential via multiple receptor–ligand interactions in the process of tumor vascular development. Specifically, we uncovered an interactive GP73-mediated regulatory network coordinated with c-Myc, lactate, Janus kinase 2/signal transducer and activator of transcription 3 (JAK2/STAT3) pathway, and endoplasmic reticulum stress (ERS) signals in HCC cells and elucidated its pro-angiogenic roles in vitro and in vivo. Mechanistically, we found that GP73, the pivotal hub gene, was activated by histone lactylation and c-Myc, which stimulated the phosphorylation of downstream STAT3 by directly binding STAT3 and simultaneously enhancing glucose-regulated protein 78 (GRP78)-induced ERS. STAT3 potentiates GP73-mediated pro-angiogenic functions. Clinically, serum GP73 levels were positively correlated with HCC response to anti-angiogenic regimens and were essential for a prognostic nomogram showing good predictive performance for determining 6-month and 1-year survival in patients with HCC treated with anti-angiogenic therapy. Taken together, the aforementioned data characterized the pro-angiogenic roles and mechanisms of a GP73-mediated network and proved that GP73 is a crucial tumor angiogenesis niche gene with favorable anti-angiogenic potential in the treatment of HCC.